Obesity and cardiovascular diseases

Minerva Medica

Volumn 108, Issue 3, 2017, Pages 212-228

  Kachur, Sergey ^a   Lavie, Carl J ^b   De Schutter, Alban ^c   Milani, Richard V ^b   Ventura, Hector O ^b  

^a Ocala Orthopedic Group   (United States)

^b JOHN OCHSNER HEART AND VASCULAR INSTITUTE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary disease; Obesity; Risk factors

Indexed keywords

LEPTIN; MITOGEN ACTIVATED PROTEIN KINASE; PROPROTEIN CONVERTASE 9;

ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; ATRIAL FIBRILLATION; BODY MASS; BODY WEIGHT; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHILDHOOD OBESITY; DISEASE COURSE; DYSLIPIDEMIA; FLUID RETENTION; HEART FAILURE; HEART INFARCTION; HEART OUTPUT; HEART REHABILITATION; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIFE EXPECTANCY; LIFESTYLE MODIFICATION; LIPID STORAGE; META ANALYSIS (TOPIC); OBESITY; REVIEW; RISK FACTOR; VASCULAR DISEASE; WEIGHT REDUCTION; CARDIOVASCULAR DISEASES; COMPLICATION; CORONARY DISEASE; STROKE;

ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASES; CORONARY DISEASE; HUMANS; OBESITY; RISK FACTORS; STROKE;

EID: 85018365162     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: 10.23736/S0026-4806.17.05022-4     Document Type: Review

References (140)

1. WHO Expert Committee on Physical Status: The Use and Interpretation of Anthropometry, editor. Physical status: The use and interpretation of anthropometry: Report of a WHO Expert Committee. Geneva: World Health Organization; 1995. p. 452 (WHO technical report series).
2. Obesity and overweight. World Health Organization; 2016 [Internet]. Available from: Http://www.who.int/mediacentre/factsheets/fs311/en/[cited 2016, Dec 7].
3. Beller AS. Fat & thin: A natural history of obesity. First edition. New York: Farrar, Straus and Giroux; 1977. p. 310.
4. Bastien M, Poirier P, Lemieux I, Després J-P. Overview of Epidemiology and Contribution of Obesity to Cardiovascular Disease. Prog Cardiovasc Dis 2014;56: 369-81.
5. Dublin LI, Lotka AJ. Twenty-Five Years of Health Progress: A Study of the Mortality Experience Among Industrial Policyholders of the Metropolitan Life Insurance Company 1911-1935. New York, NY: Metropolitan Life Insurance Company; 1937.
6. Wood PA. How fat works. Cambridge, MA: Harvard University Press; 2006.
7. Perry AW. Nature and Treatment of Obesity. Cal State J Med 1903;1: 356-9.
8. R omero-Corral A, Somers VK, Sierra-Johnson J, Jensen MD, Thomas RJ, Squires RW, et al. Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease. Eur Heart J 2007;28: 2087-93.
9. R omero-Corral A, Somers VK, Sierra-Johnson J, Thomas RJ, Collazo-Clavell ML, Korinek J, et al. Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes 2008;32: 959-66.
10. Lavie CJ, McAuley PA, Church TS, Milani RV, Blair SN. Obesity and cardiovascular diseases: Implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol 2014;63: 1345-54.
11. De Schutter A, Lavie CJ, Gonzalez J, Milani RV. Body composition in coronary heart disease: How does body mass index correlate with body fatness? Ochsner J 2011;11: 220-5.
12. A shwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: Systematic review and meta-analysis: Waist-to-height ratio as a screening tool. Obes Rev 2012;13: 275-86.
13. Hu G, Tuomilehto J, Silventoinen K, Barengo N, Jousilahti P. Joint effects of physical activity, body mass index, waist circumference and waist-to-hip ratio with the risk of cardiovascular disease among middle-aged Finnish men and women. Eur Heart J 2004;25: 2212-9.
14. Saydah S, Bullard KM, Imperatore G, Geiss L, Gregg EW. Cardiometabolic Risk Factors Among US Adolescents and Young Adults and Risk of Early Mortality. Pediatrics 2013;131: E679-86.
15. Alpert MA, Omran J, Mehra A, Ardhanari S. Impact of Obesity and Weight Loss on Cardiac Performance and Morphology in Adults. Prog Cardiovasc Dis 2014;56: 391-400.
16. Moreno M, Puig J, Moreno-Navarrete JM, Xifra G, Ortega F, Ricart W, et al. Lean mass, and not fat mass, is an independent determinant of carotid intima media thick ness in obese subjects. Atherosclerosis 2015;243: 493-8.
17. Gracia-Marco L, Moreno LA, Ruiz JR, Ortega FB, de Moraes ACF, Gottrand F, et al. Body Composition Indices and Single and Clustered Cardiovascular Disease Risk Factors in Adolescents: Providing Clinical-Based Cut-Points. Prog Cardiovasc Dis 2016;58: 555-64.
18. Bigaard J, Frederiksen K, Tjønneland A, Thomsen BL, Overvad K, Heitmann BL, et al. Body Fat and Fat-Free Mass and All-Cause Mortality. Obes Res 2004;12: 1042-9.
19. Church TS, Thomas DM, Tudor-Locke C, Katzmarzyk PT, Earnest CP, Rodarte RQ, et al. Trends over 5 Decades in U.S. Occupation-Related Physical Activity and Their Associations with Obesity. Lucia A, editor. PLoS One 2011;6: E19657.
20. Flegal KM, Kit B, Orpana H, Graubard B. Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories: A Systematic Review and Meta-Analysis. JAMA 2013;309: 71-82.
21. C alori G, Lattuada G, Piemonti L, Garancini MP, Ragogna F, Villa M, et al. Prevalence, Metabolic Features, and Prognosis of Metabolically Healthy Obese Italian Individuals: The Cremona Study. Diabetes Care 2011;34: 210-5.
22. Mørkedal B, Vatten LJ, Romundstad PR, Laugsand LE, Janszky I. Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals: HUNT (Nord-Trøndelag Health Study), Norway. J Am Coll Cardiol 2014;63: 1071-8.
23. Fan J, Song Y, Chen Y, Hui R, Zhang W. Combined effect of obesity and cardio-metabolic abnormality on the risk of cardiovascular disease: A meta-analysis of prospective cohort studies. Int J Cardiol 2013;168: 4761-8.
24. Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Ann Intern Med 2013;159: 758-69.
25. Gupta S, Rohatgi A, Ayers CR, Willis BL, Haskell WL, Khera A, et al. Cardiorespiratory Fitness and Classification of Risk of Cardiovascular Disease Mortality. Circulation 2011;123: 1377-83.
26. Ortega FB, Lee D -c., Katzmarzyk PT, Ruiz JR, Sui X, Church TS, et al. The intriguing metabolically healthy but obese phenotype: Cardiovascular prognosis and role of fitness. Eur Heart J 2013;34: 389-97.
27. Lee D, Sui X, Church TS, Lavie CJ, Jackson AS, Blair SN. Changes in Fitness and Fatness on the Development of Cardiovascular Disease Risk Factors. J Am Coll Cardiol 2012;59: 665-72.
28. Kenchaiah S, Evans JC, Levy D, Wilson PWF, Benjamin EJ, Larson MG, et al. Obesity and the Risk of Heart Failure. N Engl J Med 2002;347: 305-13.
29. V oulgari C, Tentolouris N, Dilaveris P, Tousoulis D, Katsilambros N, Stefanadis C. Increased Heart Failure Risk in Normal-Weight People With Metabolic Syndrome Compared With Metabolically Healthy Obese Individuals. J Am Coll Cardiol 2011;58: 1343-50.
30. Brassard P, Legault S, Garneau C, Bogaty P, Dumesnil J-G, Poirier P. Normalization of Diastolic Dysfunction in Type 2 Diabetics after Exercise Training. Med Sci Sports Exerc 2007;39: 1896-901.
31. Alpert MA, Terry BE, Kelly DL. Effect of weight loss on cardiac chamber size, wall thickness and left ventricular function in morbid obesity. Am J Cardiol 1985;55: 783-6.
32. Elmaogullari S, Demirel F, Hatipoglu N. Risk factors that affect metabolic health status in obese children; 2016 [Internet]. Available from: Http://www.degruyter. com/view/j/jpem.ahead-of-print/jpem-2016-0128/jpem- 2016-0128.xml [cited 2016, Dec 26]
33. Parvaresh Rizi E, Baig S, Shabeer M, Teo Y, Mok SF, Loh TP, et al. Meal rich in carbohydrate, but not protein or fat, reveals adverse immunometabolic responses associated with obesity. Nutr J 2016;15: 100.
34. Khan TA, Sievenpiper JL. Controversies about sugars: Results from systematic reviews and meta-analyses on obesity, cardiometabolic disease and diabetes. Eur J Nutr 2016;55(Suppl 2): 25-43.
35. Sridhar GR, Sanjana NSN. Sleep, circadian dysrhythmia, obesity and diabetes. World J Diabetes 2016;7: 515.
36. R ao MN, Neylan TC, Grunfeld C, Mulligan K, Schambelan M, Schwarz J-M. Subchronic Sleep Restriction Causes Tissue-Specific Insulin Resistance. J Clin Endocrinol Metab 2015;100: 1664-71.
37. Lusis AJ. Atherosclerosis. Nature 2000;407: 233-41.
38. Mathieu P, Poirier P, Pibarot P, Lemieux I, Despres J-P. Visceral Obesity: The Link Among Inflammation, Hypertension, and Cardiovascular Disease. Hypertension 2009;53: 577-84.
39. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: A 26- year follow-up of participants in the Framingham Heart Study. Circulation 1983;67: 968-77.
40. Rabkin SW, Mathewson FAL, Hsu P-H. Relation of body weight to development of ischemic heart disease in a cohort of young north American men after a 26 year observation period: The manitoba study. Am J Cardiol 1977;39: 452-8.
41. Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, et al. Body Weight and Mortality among Women. N Engl J Med 1995;333: 677-85.
42. Krauss RM, Winston M, Fletcher BJ, Grundy SM. Obesity: Impact on Cardiovascular Disease. Circulation 1998;98: 1472-6.
43. C assidy AE. Progression of Subclinical Coronary Atherosclerosis: Does Obesity Make a Difference? Circulation 2005;111: 1877-82.
44. Madala MC, Franklin BA, Chen AY, Berman AD, Roe MT, Peterson ED, et al. Obesity and Age of First Non- ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol 2008;52: 979-85.
45. Li P, Wang L, Liu C. Overweightness, obesity and arterial stiffness in healthy subjects: A systematic review and meta-analysis of literature studies. Postgrad Med 2016;15: 1-7.
46. A rcaro G, Zamboni M, Rossi L, Turcato E, Covi G, Armellini F, et al. Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int J Obes Relat Metab Disord 1999;23: 936-42.
47. Marin MT, Dasari PS, Tryggestad JB, Aston CE, Teague AM, Short KR. Oxidized HDL and LDL in adolescents with type 2 diabetes compared to normal weight and obese peers. J Diabetes Complications 2015;29: 679-85.
48. Kortelainen M-L, Särkioja T. Visceral fat and coronary pathology in male adolescents. Int J Obes 2001;25: 228-32.
49. Freedman DS, Dietz WH, Tang R, Mensah GA, Bond MG, Urbina EM, et al. The relation of obesity throughout life to carotid intima-media thickness in adulthood: The Bogalusa Heart Study. Int J Obes 2003;28: 159-66.
50. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older Adults. N Engl J Med 1999;340: 14-22.
51. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: The Rotterdam Study. Circulation 1997;96: 1432-7.
52. McGill HC, McMahan CA, Malcom GT, Oalmann MC, Strong JP. Relation of Glycohemoglobin and Adiposity to Atherosclerosis in Youth. Arteriosclerosis, Thrombosis, and Vascular Biology 1995;15: 431-40.
53. Bibbins-Domingo K, Coxson P, Pletcher MJ, Lightwood J, Goldman L. Adolescent Overweight and Future Adult Coronary Heart Disease. N Engl J Med 2007;357: 2371-9.
54. Wilson PWF, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and Obesity as Determinants of Cardiovascular Risk: The Framingham Experience. Arch Intern Med 2002;162: 1867.
55. Gelber R, Gaziano J, Manson J, Buring J, Sesso H. A Prospective Study of Body Mass Index and the Risk of Developing Hypertension in Men. American Journal of Hypertension 2007;20: 370-7.
56. Brion MA, Ness AR, Davey Smith G, Leary SD. Association between body composition and blood pressure in a contemporary cohort of 9-year-old children. J Hum Hypertens 2007;21: 283-90.
57. Moore LL, Visioni AJ, Qureshi MM, Bradlee ML, Ellison RC, D'Agostino R. Weight Loss in Overweight Adults and the Long-term Risk of Hypertension: The Framingham Study. Arch Intern Med 2005;165: 1298.
58. The SPRINT Research Group. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med 2015;373: 2103-16.
59. Kurth T, Gaziano JM, Berger K, Kase CS, Rexrode KM, Cook NR, et al. Body mass index and the risk of stroke in men. Arch Intern Med 2002;162: 2557-62.
60. C hen Z, Yang G, Offer A, Zhou M, Smith M, Peto R, et al. Body mass index and mortality in China: A 15- year prospective study of 220 000 men. Int J Epidemiol2012; 41: 472-81.
61. Wang TJ. Obesity and the Risk of New-Onset Atrial Fibrillation. JAMA 2004;292: 2471.
62. Wanahita N, Messerli FH, Bangalore S, Gami AS, Somers VK, Steinberg JS. Atrial fibrillation and obesity-results of a meta-analysis. Am Heart J 2008;155: 310-5.
63. Alpert MA, Terry BE, Mulekar M, Cohen MV, Massey CV, Fan TM, et al. Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss. Am J Cardiol 1997;80: 736-40.
64. Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M, ADHERE Scientific Advisory Committee and Investigators. An obesity paradox in acute heart failure: Analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 2007;153: 74-81.
65. Lavie CJ, De Schutter A, Milani RV. Healthy obese versus unhealthy lean: The obesity paradox. Nat Rev Endocrinol 2015;11: 55-62.
66. A hmad FS, Ning H, Rich JD, Yancy CW, Lloyd-Jones DM, Wilkins JT. Hypertension, Obesity, Diabetes, and Heart Failure-Free Survival. JACC Heart Fail 2016;4: 911-9.
67. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA 2003;289: 187-93.
68. C alle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW. Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults. N Engl J Med 1999;341: 1097-105.
69. Oreopoulos A, Padwal R, Norris CM, Mullen JC, Pretorius V, Kalantar-Zadeh K. Effect of Obesity on Shortand Long-term Mortality Postcoronary Revascularization: A Meta-analysis. Obesity 2008;16: 442-50.
70. Stamou SC, Nussbaum M, Stiegel RM, Reames MK, Skipper ER, Robicsek F, et al. Effect of Body Mass Index on Outcomes After Cardiac Surgery: Is There an Obesity Paradox? Ann Thorac Surg 2011;91: 42-7.
71. Hamer M, Stamatakis E. Overweight and obese cardiac patients have better prognosis despite reporting worse perceived health and more conventional risk factors. Prev Med 2013;57: 12-6.
72. Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Thomas AG, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: A systematic review of cohort studies. Lancet 2006;368: 666-78.
73. Doehner W, Clark A, Anker SD. The obesity paradox: Weighing the benefit. Eur Heart J 2010;31: 146-8.
74. Childers DK, Allison DB. The "obesity paradox": A parsimonious explanation for relations among obesity, mortality rate and aging? Int J Obes 2010;34: 1231-8.
75. Ortega FB, Lavie CJ, Blair SN. Obesity and Cardiovascular Disease. Circ Res 2016;118: 1752-70.
76. Dhana K, Koolhaas CM, van Rossum EFC, Ikram MA, Hofman A, Kavousi M, et al. Metabolically Healthy Obesity and the Risk of Cardiovascular Disease in the Elderly Population. Li Y, editor. Plos One 2016;11: E0154273.
77. Katzmarzyk PT, Church TS, Janssen I, Ross R, Blair SN. Metabolic syndrome, obesity, and mortality: Impact of cardiorespiratory fitness. Diabetes Care 2005;28: 391-7.
78. McAuley PA, Artero EG, Sui X, Lee D, Church TS, Lavie CJ, et al. The Obesity Paradox, Cardiorespiratory Fitness, and Coronary Heart Disease. Mayo Clin Proc 2012;87: 443-51.
79. Goel K, Thomas RJ, Squires RW, Coutinho T, Trejo-Gutierrez JF, Somers VK, et al. Combined effect of cardiorespiratory fitness and adiposity on mortality in patients with coronary artery disease. Am Heart J 2011;161: 590-7.
80. Lavie CJ, Cahalin L, Myers JN, Bensimhon D, Peberdy MA, Ashley E, et al. Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin Proc 2013;88: 251-8.
81. Gregg EW, Gerzoff RB, Thompson TJ, Williamson DF. Intentional weight loss and death in overweight and obese U.S. adults 35 years of age and older. Ann Intern Med 2003;138: 383-9.
82. Allison DB, Zannolli R, Faith MS, Heo M, Pietrobelli A, VanItallie TB, et al. Weight loss increases and fat loss decreases all-cause mortality rate: Results from two independent cohort studies. Int J Obes Relat Metab Disord 1999;23: 603-11.
83. Sierra-Johnson J, Romero-Corral A, Somers VK, Lopez- Jimenez F, Thomas RJ, Squires RW, et al. Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index. Eur J Cardiovasc Prev Rehabil 2008;15: 336-40.
84. Lavie CJ, De Schutter A, Patel DA, Milani RV. Body composition and fitness in the obesity paradox-Body mass index alone does not tell the whole story. Prev Med 2013;57: 1-2.
85. De Schutter A, Lavie CJ, Kachur S, Patel DA, Milani RV. Body composition and mortality in a large cohort with preserved ejection fraction: Untangling the obesity paradox. Mayo Clin Proc 2014;89: 1072-9.
86. Budoff MJ. Exercise capacity and biological age. Heart 2016;102: 415.
87. Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA. Body mass index and mortality in heart failure: A meta-analysis. Am Heart J 2008;156: 13-22.
88. Mohamed-Ali V, Goodrick S, Bulmer K, Holly JM, Yudkin JS, Coppack SW. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol 1999;277(6 Pt 1): E971-975.
89. Mehra MR, Uber PA, Park MH, Scott RL, Ventura HO, Harris BC, et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol 2004;43: 1590-5.
90. Rauchhaus M, Coats AJ, Anker SD. The endotoxin-lipoprotein hypothesis. The Lancet 2000;356: 930-3.
91. Bell BB, Rahmouni K. Leptin as a Mediator of Obesity- Induced Hypertension. Curr Obes Rep 2016;5: 397-404.
92. Stepniakowski KT, Goodfriend TL, Egan BM. Fatty acids enhance vascular alpha-adrenergic sensitivity. Hypertension 1995;25(4 Pt 2): 774-8.
93. Hall JE, Hildebrandt DA, Kuo J. Obesity hypertension: Role of leptin and sympathetic nervous system. Am J Hypertens 2001;14(6 Pt 2): 103S-115S.
94. Oishi K, Zheng B, Kuo JF. Inhibition of Na,K-ATPase and sodium pump by protein kinase C regulators sphingosine, lysophosphatidylcholine, and oleic acid. J Biol Chem 1990;265: 70-5.
95. Taddei S, Virdis A, Mattei P, Favilla S, Salvetti A. Angiotensin II and Sympathetic Activity in Sodium-Restricted Essential Hypertension. Hypertension 1995;25: 595-601.
96. Kalupahana NS, Moustaid-Moussa N. The adipose tissue renin-angiotensin system and metabolic disorders: A review of molecular mechanisms. Crit Rev Biochem Mol Biol 2012;47: 379-90.
97. Hall JE. Pathophysiology of obesity hypertension. Curr Hypertens Rep 2000;2: 139-47.
98. Hall J. Mechanisms of Abnormal Renal Sodium Handling in Obesity Hypertension. Am J Hypertens 1997;10: 49S-55S.
99. Bray GA. Medical Consequences of Obesity. J Clin Endocrinol Metab 2004;89: 2583-9.
100. Alpert MA, Lambert CR, Panayiotou H, Terry BE, Cohen MV, Massey CV, et al. Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss. Am J Cardiol 1995;76: 1194-7.
101. Ku C-S, Lin S-L, Wang D-J, Chang S-K, Lee W-J. Left ventricular filling in young normotensive obese adults. Am J Cardiol 1994;73: 613-5.
102. Poirier P. Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006;113: 898-918.
103. N eeland IJ, Gupta S, Ayers CR, Turer AT, Rame JE, Das SR, et al. Relation of Regional Fat Distribution to Left Ventricular Structure and Function. Circ Cardiovasc Imaging 2013;6: 800-7.
104. Kankaanpää M, Lehto H-R, Pärkkä JP, Komu M, Viljanen A, Ferrannini E, et al. Myocardial Triglyceride Content and Epicardial Fat Mass in Human Obesity: Relationship to Left Ventricular Function and Serum Free Fatty Acid Levels. J Clin Endocrinol Metab 2006;91: 4689-95.
105. Alpert MA. Obesity cardiomyopathy: Pathophysiology and evolution of the clinical syndrome. Am J Med Sci 2001;321: 225-36.
106. I acobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappaterreno A, et al. Echocardiographic Epicardial Adipose Tissue Is Related to Anthropometric and Clinical Parameters of Metabolic Syndrome: A New Indicator of Cardiovascular Risk. J Clin Endocrinol Metab 2003;88: 5163-8.
107. Peterson LR. Effect of Obesity and Insulin Resistance on Myocardial Substrate Metabolism and Efficiency in Young Women. Circulation 2004;109: 2191-6.
108. Liu S, Geng B, Zou L, Wei S, Wang W, Deng J, et al. Development of hypertrophic cardiomyopathy in perilipin- 1 null mice with adipose tissue dysfunction. Cardiovascr Res 2015;105: 20-30.
109. Ruiz-Ramírez A, López-Acosta O, Barrios-Maya MA, El-Hafidi M. Cell Death and Heart Failure in Obesity: Role of Uncoupling Proteins. Oxid Med Cell Longev 2016;2016: 1-11.
110. Murray AJ, Anderson RE, Watson GC, Radda GK, Clarke K. Uncoupling proteins in human heart. The Lancet 2004;364: 1786-8.
111. Rider OJ, Cox P, Tyler D, Clarke K, Neubauer S. Myocardial substrate metabolism in obesity. Int J Obes 2013;37: 972-9.
112. Libby P, Ridker PM, Hansson GK. Inflammation in Atherosclerosis. J Am Coll Cardiol 2009;54: 2129-38.
113. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007;117: 175-84.
114. V isser M. Elevated C-Reactive Protein Levels in Overweight and Obese Adults. JAMA 1999;282: 2131.
115. Van de Voorde J, Pauwels B, Boydens C, Decaluwé K. Adipocytokines in relation to cardiovascular disease. Metabolism 2013;62: 1513-21.
116. Hernandez-Pando R, Bornstein QL, Aguilar Leon D, Orozco EH, Madrigal VK, Martinez Cordero E. Inflammatory cytokine production by immunological and foreign body multinucleated giant cells. Immunology 2000;100: 352-8.
117. D espres JP, Krauss RM. Obesity and lipoprotein metabolism. In: Handbook of Obesity: Etiology and pathophysiology. Second edition. New York: Marcel Dekker; 2004. p. 845-71.
118. Song G, Wu X, Zhang P, Yu Y, Yang M, Jiao P, et al. High-density lipoprotein inhibits ox-LDL-induced adipokine secretion by upregulating SR-BI expression and suppressing ER Stress pathway. Sci Rep 2016;6: 30889.
119. Tabas I, Williams KJ, Boren J. Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis: Update and Therapeutic Implications. Circulation 2007;116: 1832-44.
120. Kulanuwat S, Tungtrongchitr R, Billington D, Davies IG. Prevalence of plasma small dense LDL is increased in obesity in a Thai population. Lipids Health Dis 2015;14: 30
121. N orris AL, Steinberger J, Steffen LM, Metzig AM, Schwarzenberg SJ, Kelly AS. Circulating Oxidized LDL and Inflammation in Extreme Pediatric Obesity. Obesity 2011;19: 1415-9.
122. Holvoet P, Kritchevsky SB, Tracy RP, Mertens A, Rubin SM, Butler J, et al. The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in wellfunctioning elderly people in the health, aging, and body composition cohort. Diabetes 2004;53: 1068-73.
123. Holvoet P, Mertens A, Verhamme P, Bogaerts K, Beyens G, Verhaeghe R, et al. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2001;21: 844-8.
124. D u Y, Li S, Cui C-J, Zhang Y, Yang S-H, Li J-J. Leptin decreases the expression of low-density lipoprotein receptor via PCSK9 pathway: Linking dyslipidemia with obesity. J Transl Med 2016;14: 276.
125. Swift DL, Johannsen NM, Lavie CJ, Earnest CP, Church TS. The Role of Exercise and Physical Activity in Weight Loss and Maintenance. Prog Cardiovasc Dis 2014;56: 441-7.
126. Artero EG, Lee D, Ruiz JR, Sui X, Ortega FB, Church TS, et al. A Prospective Study of Muscular Strength and All-Cause Mortality in Men With Hypertension. J Am Coll Cardiol 2011;57: 1831-7.
127. A lves AJ, Ribeiro F, Goldhammer E, Rivlin Y, Rosenschein U, Viana JL, et al. Exercise Training Improves Diastolic Function in Heart Failure Patients. Med Sci Sports Exerc 2012;44: 776-85.
128. Milani RV, Lavie CJ. Prevalence and profile of metabolic syndrome in patients following acute coronary events and effects of therapeutic lifestyle change with cardiac rehabilitation. Am J Cardiol 2003;92: 50-4.
129. Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K, et al. Exercise-based rehabilitation for patients with coronary heart disease: Systematic review and meta- Analysis of randomized controlled trials. Am J Med 2004;116: 682-92.
130. E ilat-Adar S. Association of Intentional Changes in Body Weight with Coronary Heart Disease Event Rates in Overweight Subjects Who Have an Additional Coronary Risk Factor. Am J Epidemiol 2005;161: 352-8.
131. A rtham SM, Lavie CJ, Milani RV , Ventura HO. Value of Weight Reduction in Patients with Cardiovascular Disease. Curr Treat Options Cardiovasc Med 2010;12: 21-35.
132. Lavie CJ, De Schutter A, Patel D, Artham SM, Milani RV. Body Composition and Coronary Heart Disease Mortality-An Obesity or a Lean Paradox? Mayo Clin Proc 2011;86: 857-64.
133. Martin B-J, Arena R, Haykowsky M, Hauer T, Austford LD, Knudtson M, et al. Cardiovascular Fitness and Mortality After Contemporary Cardiac Rehabilitation. Mayo Clin Proc 2013;88: 455-63.
134. Kodama S. Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events in Healthy Men and Women: A Meta-analysis. JAMA 2009;301: 2024.
135. Alamuddin N, Bakizada Z, Wadden TA. Management of Obesity. J Clin Oncol 2016;34: 4295-305.
136. Lichtenstein AH. Diet and Lifestyle Recommendations Revision 2006: A Scientific Statement From the American Heart Association Nutrition Committee. Circulation 2006;114: 82-96.
137. Zhang X, Imperatore G, Thomas W, Cheng YJ, Lobelo F, Norris K, et al. Effect of lifestyle interventions on glucose regulation among adults without impaired glucose tolerance or diabetes: A systematic review and metaanalysis. Diabetes Res Clin Pract 2017;123: 149-64.
138. Medications Target Long-Term Weight Control; [Internet]. Available from: Http://www.fda.gov/downloads/ForConsumers/ConsumerUpdates/UCM312391.pdf [cited 2016, Dec 28].
139. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. N Engl J Med 2002;346: 393-403.
140. E vers SS, Sandoval DA, Seeley RJ. The Physiology and Molecular Underpinnings of the Effects of Bariatric Surgery on Obesity and Diabetes. Annu Rev Physiol 2016 [Epub ahead of print].